Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-30 Purchase | 2022-04-01 4:16 pm | NeuBase Therapeutics Inc. | NBSE | Mann William Roland Chief Operating Officer | 6,200 | $1.92 | $11,904 | 11,200 (Direct) | View |
| 2021-04-26 Purchase | 2021-04-27 4:01 pm | NeuBase Therapeutics Inc. | NBSE | Mann William Roland COO | 5,000 | $5 | $25,000 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-24 Option Award | 2022-01-25 2:03 pm | N/A 2032-01-24 | NeuBase Therapeutics Inc. | NBSE | Mann William Roland Chief Operating Officer | 60,180 | $0 | 60,180 (Direct) | View |
| 2021-08-16 Option Award | 2021-09-24 5:03 pm | N/A 2031-08-16 | NeuBase Therapeutics Inc. | NBSE | Mann William Roland COO | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-07-27 Option Award | 2020-07-28 4:22 pm | N/A 2030-07-27 | NeuBase Therapeutics Inc. | NBSE | Mann William Roland COO | 175,000 | $0 | 175,000 (Direct) | View |